Carterra Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$25.5M
Industry:Biotech
Founded:2005
Lead Investor(s):Telegraph Hill Partners
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Carterra's estimated revenue is currently $11.5M per year.
  • Carterra received $10.0M in venture funding in January 2018.
  • Carterra's estimated revenue per employee is $212963
  • Carterra's total funding is $25.5M.

Employee Data

  • Carterra has 54 Employees.
  • Carterra grew their employee count by 46% last year.
  • Carterra currently has 2 job openings.

Executive Contacts

NameTitle
Steve ChipchaseVice President Operations
Tim GermannChief Commercial Officer
Chris MorrowDirector Of Engineering
Steve WoodDirector Of Manufacturing Operations
Tim GermannVice President, Global Sales and Service

What Is Carterra?

Carterra, formerly Wasatch Microfluidics, develops high throughput surface plasmon resonance array-based platforms for biomolecular interaction analysis. Our new name is based on two core concepts: Cartography (mapping) and terra (worlds), literally meaning mapping worlds. This represents the Company's high-speed, high-resolution label-free biosensor technologies, which are being used by leading pharmaceutical and biotechnology companies to thoroughly explore their large monoclonal antibody (mAb) libraries to discover novel biotherapeutic candidates.

keywords:Biotechnology,Healthcare

54

Number of Employees

$11.5M

Revenue (est)

2

Current Jobs

46%

Employee Growth %

$25.5M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Predictive Biot...
N/A5627%
ZYTO
$7.3M526%
Scientific Comp...
N/A38-21%
PolarityTE
$1.6M10424%$17.8M
Carterra
$11.5M5446%$25.5M

Carterra News

09/03/2019 - Bristol-Meyers Squibb, Boehringer Ingelheim and Other ...

Bristol-Meyers Squibb, Boehringer Ingelheim and Other Biotechnology Companies to Present Use of Carterra's Next Generation Antibody ...

09/08/2019 - Rapid European adoption of Carterra’s LSA platform fuels expansion

Carterra® Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a ...

09/03/2019 - Advancing Therapeutic Antibodies With New Surface Plasmon Resonance Technology

Carterra® Inc., will host a series of symposia across the United States and Europe entitled, The therapeutic antibody revolution in the ...

Carterra Funding

DateAmountRoundLead InvestorsReference
2014-07-02$2.0MUndisclosedBioFire DiagnosticsArticle
2016-08-22$10.3MUndisclosedArticle
2018-01-18$10.0MUndisclosedTelegraph Hill PartnersArticle